Compare NOV & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NOV | IRTC |
|---|---|---|
| Founded | 1862 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 5.8B |
| IPO Year | 1996 | 2016 |
| Metric | NOV | IRTC |
|---|---|---|
| Price | $16.36 | $169.94 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 13 | 14 |
| Target Price | $15.69 | ★ $203.93 |
| AVG Volume (30 Days) | ★ 3.5M | 454.2K |
| Earning Date | 10-27-2025 | 10-30-2025 |
| Dividend Yield | ★ 1.83% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.00 | N/A |
| Revenue | ★ $8,775,000,000.00 | $702,573,000.00 |
| Revenue This Year | N/A | $27.20 |
| Revenue Next Year | N/A | $16.89 |
| P/E Ratio | $16.45 | ★ N/A |
| Revenue Growth | N/A | ★ 25.45 |
| 52 Week Low | $10.84 | $84.17 |
| 52 Week High | $16.96 | $212.00 |
| Indicator | NOV | IRTC |
|---|---|---|
| Relative Strength Index (RSI) | 61.98 | 38.34 |
| Support Level | $15.88 | $166.76 |
| Resistance Level | $16.96 | $187.98 |
| Average True Range (ATR) | 0.45 | 6.55 |
| MACD | 0.05 | -1.41 |
| Stochastic Oscillator | 73.73 | 9.08 |
NOV (formerly National Oilwell Varco) is a leading supplier of oil and gas drilling rig equipment and products, such as downhole tools, drill pipe, and well casing. The company operates on a global scale, with international markets contributing nearly two thirds of its annual revenue.
iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.